2206135-30-8 | 帕布昔利布标准品012 |
2206135-48-8 | 富马酸喹硫平杂质 |
2206135-50-2 | 喹硫平杂质 |
2206230-32-0 | (R)-2-(4-甲基哌嗪-1-基)丙酸盐酸 |
2206265-54-3 | 1-(2-氟-4-甲基苯基)乙烷-1-胺盐酸盐 |
2206320-30-9 | 2,4-Dichloro-6-ethoxyquinazoline |
2206360-62-3 | 左氧氟沙星杂质5 |
2206360-74-7 | 利伐沙班杂质35 |
2206360-84-9 | Rivaroxaban Impurity 49 |
2206568-00-3 | 二-叔-丁基 1-(3-甲基苯甲基)肼-1,2-二甲酸基酯 |
2206606-86-0 | Aprepitant EP Impurity B |
2206606-97-3 | 喹硫平杂质6 |
2206608-00-4 | 1-(4-Chloro-2-fluorophenyl)-ethylamine hydrochloride |
2206608-25-3 | (S)-(四氢-2H-吡喃-2-基)甲胺盐酸盐 |
2206609-91-6 | 1-(2-(甲氨基)乙基)哌啶-4-醇盐酸盐 |
2206610-58-2 | 2,9-二氮杂螺[3-5]叔丁基-9-羧酸叔丁酯草酸盐 |
2206610-69-5 | 1-oxa-8-azaspiro[4.5]decan-3-ol hydrochloride |
2206677-06-5 | CAY10730 |
2206677-82-7 | IDT-C8-2CHO |
2206735-61-5 | KRAS G12C INHIBITOR 2 |
2206735-75-1 | KRAS G12C INHIBITOR 3 |
2206736-04-9 | MRTX-1257 |
2206736-07-2 | KRAS G12C INHIBITOR 4 |
2206737-02-0 | |
2206737-03-1 | |
2206737-05-3 | 1-Piperazinecarboxylic acid, 2-(cyanomethyl)-4-[5,6,7,8-tetrahydro-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[3,4-d]pyrimidin-4-yl]-, 1,1-dimethylethyl ester, (2S)- |
2206737-06-4 | 2-((S)-4-(7-(8-氯萘-1-基)-2-((((S)-1-甲基吡咯烷-2-基)甲氧基)-5,6,7,8-四氢吡啶基 [3,4-D]嘧啶-4-基)哌嗪-2-基)乙腈 |
2206737-78-0 | ((2S,4R)-4-氟-1-甲基吡咯烷-2-基)甲醇 |
2206741-04-8 | 1-溴-8-乙基萘 |
2206741-25-3 | 2206741-25-3 |
2206741-27-5 | 2206741-27-5 |
2206742-47-2 | 4-溴-5,6-二甲基-1H-吲唑 |
2206742-48-3 | 4-溴-5,6-二甲基-1-(四氢-2H-吡喃-2-基)-1H-吲唑 |
2206788-99-8 | CCR4 antagonist 2 |
2206792-50-7 | SASANLIMAB (萨善利单抗 ) |
2206821-02-3 | 2-Pyridinecarboxamide, 5,6-dichloro-N,N-dimethyl- |
2206825-58-1 | 7-氧代-1-氮杂螺[4.4]壬烷-1-羧酸叔丁酯 |
2206825-81-0 | 阿哌沙班杂质44 |
2206825-87-6 | 阿哌沙班氨基酸杂质 |
2206825-95-6 | Levofloxacin Impurity 23 |
2206826-82-4 | PraMipexole DiMer IMpurity II |
2206827-12-3 | Sorafenib impurity 16/Ethyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate |
2206827-14-5 | Sorafenib impurity 14/Isopropyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate |
2206970-15-0 | (3-Iodophenyl)acetic acid tert-butyl ester |
2207524-70-5 | (3R)-3-Aminobutan-1-ol hydrochloride |
2207528-55-8 | Ticagrelor Related Compound 93 |
2207541-23-7 | 3-[1,3-DIHYDRO-4-(4-HYDROXY-1-BUTYN-1-YL)-1-OXO-2H-ISOINDOL-2-YL]-2,6-PIPERIDINEDIONE |
2207541-30-6 | 3-(4-碘-1-氧代异吲哚啉-2-基)哌啶-2,6-二酮 |
2207569-08-0 | QCA570 |
2207590-51-8 | 拉格芙利单抗 |
2207596-93-6 | MPEG11-CH2CH2COONHS |
2207600-84-6 | (S)-3,3'-双(10-苯基-9-蒽基)-1,1'-联萘-2,2'-二基磷酸氢酯(请以英文为准,中文仅做参考) |
2207601-04-3 | (3S,3'S)-3,3'-二叔丁基-2,2',3,3'-四氢-4,4'-双-1,3-苯并氧磷杂环戊二烯 |
2207601-10-1 | (2S,2'S,3S,3'S)-3,3'-di-tert-butyl-2,2'-dimethyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole |
2207601-12-3 | (2S,2'S,3S,3'S)-3,3'-二叔丁基-2,2'-二异丙基-2,2',3,3'-四氢-4,4'-二苯并[D][ 1,3]氧杂磷杂环戊烯 |
2207870-15-1 | 5-氮杂螺[2.4]庚烷-7-羧酸甲酯盐酸盐 |
2207960-17-4 | 1-(4-甲氧基-1-甲基-1H-吡唑-3-基)乙醇 |
2208138-72-9 | (R)-5-氨基-5,6,7,8-四氢萘-2-甲腈盐酸盐 |
2208275-54-9 | 阿哌沙班杂质28 |
2208275-99-2 | 阿瑞匹坦EP杂质C |
2208746-53-4 | 甲基 3-(哌嗪-1-基)苯酸盐盐酸 |
2208779-90-0 | 1-(2-Fluoro-4-methylbenzyl)-piperazine dihydrochloride |
2208780-63-4 | (S)-(-)-Ofloxacin-d3 (N-methyl-d3) |
2208821-82-1 | 5-氨基-4-氯-2-硝基苯甲酸乙酯 |
2209040-18-4 | N,9,9-三苯基-N-(4-(三苯基甲硅烷基)-4-联苯基)芴-2-胺 |
2209045-57-6 | 2,5-苯基-N,N-二(4-羧基苯基)-[3,2-B]吡咯并吡咯 |
2209053-93-8 | PDGFRα kinase inhibitor 1 |
2209078-25-9 | (S,E)-METHYL 2-AMINO-4-(4-FLUOROPHENYL)BUT-3-ENOATE HCL |
2209082-58-4 | 2-氯-2-硼酸联苯 |
2209085-22-1 | JH-XI-10-02 |
2209085-45-8 | N-[3-(11,12-二脱氢二苯并[B,F]]氮杂环辛-5(6H)-基)-3-氧代丙基]脲 |
2209086-92-8 | 1-[(1S,2S)-2-(二甲基氨基)环己基]-3-(五氟苯基)硫脲 |
2209087-06-7 | Bis(6-methylheptyl) Phthalate-3,4,5,6-d4 |
2209087-17-0 | (2R)-2-[[[[3,5-
Bis(trifluoromethyl)phenyl]amino]thioxomethyl]amino]-
3,3-dimethyl-N-(phenylmethyl)butanamide |
2209090-37-7 | Thiophene, 5-bromo-3-fluoro-2-hexyl- |
2209109-64-6 | |
2209112-05-8 | 6-(trifluoromethyl)-2-azaspiro[3.3]heptane hydrochloride |
2209112-96-7 | AMYCOLATOPSIN A |
2209112-97-8 | |
2209833-23-6 | O-Allyl-L-Ser-HCl |
2209881-38-7 | 13H-螺[苯并[C]茚并[2,1-A]咔唑-14,9'-芴 |
2209911-80-6 | 盐酸柯诺拉赞 |
2210228-45-6 | [1,1'-Biphenyl]-3-carboxamide, 4'-[[[1-(cyclopropylcarbonyl)-1,2,3,4-tetrahydro-7-quinolinyl]amino]sulfonyl]- |
2210228-73-0 | Bortezomib Impurity 60 |
2210244-83-8 | (FREEBASE) |
2210247-59-7 | L-ALANINAMIDE, N-[31-(2,5-DIHYDRO-2,5-DIOXO-1H-PYRROL-1-YL)-1,29-DIOXO-4,7,10,13,16,19,22,25-OCTAOXA-28-AZAHENTRIACONT-1-YL]-L-VALYL-N-[4-[[[(4-NITROPHENOXY)CAR |
2210254-25-2 | 1,3,2-Dioxaborolane, 2-(2'-chloro[1,1'-biphenyl]-2-yl)-4,4,5,5-tetramethyl- |
2210262-72-7 | |
2210266-88-7 | |
2210266-91-2 | |
2211054-17-8 | 马西替坦杂质16 |
2211054-46-3 | 马昔腾坦杂质QTH |
2211054-90-7 | Macitentan Impurity 2 |
2211057-81-5 | 中间体 |
2211059-00-4 | N-[5-(4-Bromophenyl)-6-[2-(2-pyrimidinyloxy)ethoxy]-4-pyrimidinyl]-N''-propyl-sulfamide |
2211059-05-9 | Macitentan Hydroxy amine Impurity |
2211060-61-4 | Antifungal agent 2 |
2211082-53-8 | GUNAGRATINIB |
2211097-75-3 | Acotiamide Impurity 21 |
2211174-73-9 | Thiol-PEG12-acid |